In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1834 News Items found
DJ and MSK patient Cynthia Malaran performing joyfully at South Street Seaport
Quieting Cancer Anxiety With Music Therapy

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits.
Finding
Dr. Roni Shouval
Successful CAR T Treatment for Large B Cell Lymphoma May Depend on Circadian Rhythms

An international study led by MSK researchers has found that, when used to treat large B cell lymphoma, CAR T immunotherapy may work better when given earlier in the day.
MSK patient Charisma McDuffie is seen smiling outdoors.
The Latest Research on Why So Many Young Adults Are Getting Cancer

Learn about the latest research on why more young adults are developing cancer, from investigators across MSK.
Article
MSK radiation oncologist and head and neck specialist Dr. Nadeem Riaz.
Treatment for Head and Neck Squamous Cell Carcinoma Affected by Bacteria Inside the Tumors

Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.
Dr. Michael Kharas in the lab
New Research Finds Genetic Variant in the MSI2 Gene May Prevent Certain Blood Cancers 

Scientists have discovered an inherited gene variant that may reduce the risk of developing certain blood cancers.
Feature
Dr. Prasad Adusumilli sits at a computer. A patient’s face and a chest image are on the screen.
MSK Offers Second Opinions for Cancer Diagnosis: 9 Things Patients Should Know

Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.
Q&A
MSK urologic surgeon and prostate cancer specialist Jonathan Fainberg
What To Know About Prostate Removal Surgery, Side Effects, and Recovery

Prostate cancer expert Jonathan Fainberg, MD, discusses the risk of complications from prostate cancer surgery and explains why not all procedures are alike.
A researcher working in an MSK lab
MSK Research Highlights, December 16, 2025

New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model.
microscope image of regulatory T cells
MSK Researchers Solve a Key Colorectal Cancer Mystery

A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.
MSK patient Ellen Coopersmith smiling in a rowboat in Central Park
MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.